WHO. World malaria report 2022. Geneva: World Health Organization; 2022.
WHO. World malaria report 2021. Geneva: World Health Organization; 2021.
Andolina C, Rek JC, Briggs J, Okoth J, Musiime A, Ramjith J, et al. Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study. Lancet Infect Dis. 2021;21:1568–78.
Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008;372:1545–54.
Ceesay SJ, Casals-Pascual C, Nwakanma DC, Walther M, Gomez-Escobar N, Fulford AJC, et al. Continued decline of malaria in The Gambia with implications for elimination. PLoS ONE. 2010;5: e12242.
Ahmad A, Mohammed NI, Joof F, Affara M, Jawara M, Abubakar I, et al. Asymptomatic Plasmodium falciparum carriage and clinical disease: a 5-year community-based longitudinal study in The Gambia. Malar J. 2023;22:82.
Mooney JP, DonVito SM, Jahateh M, Bittaye H, Bottomley C, D’Alessandro U, et al. Dry season prevalence of Plasmodium falciparum in asymptomatic Gambian children, with a comparative evaluation of diagnostic methods. Malar J. 2022;21:171.
Mwesigwa J, Achan J, Di Tanna GL, Affara M, Jawara M, Worwui A, et al. Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions. PLoS ONE. 2017;12: e0187059.
Collins KA, Ceesay S, Drammeh S, Jaiteh FK, Guery MA, Lanke K, et al. A cohort study on the duration of Plasmodium falciparum infections during the dry season in The Gambia. J Infect Dis. 2022;226:128–37.
Buchwald AG, Sixpence A, Chimenya M, Damson M, Sorkin JD, Wilson ML, et al. Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi. Clin Infect Dis. 2019;68:106–12.
Males S, Gaye O, Garcia A. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. Clin Infect Dis. 2008;46:516–22.
Portugal S, Tran TM, Ongoiba A, Bathily A, Li S, Doumbo S, et al. Treatment of chronic asymptomatic Plasmodium falciparum infection does not increase the risk of clinical malaria upon reinfection. Clin Infect Dis. 2017;64:645–53.
Sondén K, Doumbo S, Hammar U, VafaHomann M, Ongoiba A, Traoré B, et al. Asymptomatic multiclonal Plasmodium falciparum infections carried through the dry season predict protection against subsequent clinical malaria. J Infect Dis. 2015;212:608–16.
Bereczky S, Liljander A, Rooth I, Faraja L, Granath F, Montgomery SM, et al. Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. Microbes Infect. 2007;9:103–10.
Le Port A, Cot M, Etard J-F, Gaye O, Migot-Nabias F, Garcia A. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Malar J. 2008;7:193.
Liljander A, Bejon P, Mwacharo J, Kai O, Ogada E, Peshu N, et al. Clearance of asymptomatic P. falciparum infections interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children. PLoS ONE. 2011;6: e16940.
Sumner KM, Mangeni JN, Obala AA, Freedman E, Abel L, Meshnick SR, et al. Impact of asymptomatic Plasmodium falciparum infection on the risk of subsequent symptomatic malaria in a longitudinal cohort in Kenya. Elife. 2021;10: e68812.
Wamae K, Wambua J, Nyangweso G, Mwambingu G, Osier F, Ndung’u F, et al. Transmission and age impact the risk of developing febrile malaria in children with asymptomatic Plasmodium falciparum parasitemia. J Infect Dis. 2019;219:936–44.
Eldh M, Hammar U, Arnot D, Beck H-P, Garcia A, Liljander A, et al. Multiplicity of asymptomatic Plasmodium falciparum infections and risk of clinical malaria: a systematic review and pooled analysis of individual participant data. J Infect Dis. 2020;221:775–85.
Mwesigwa J, Okebe J, Affara M, Di Tanna GL, Nwakanma D, Janha O, et al. On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey. Malar J. 2015;14:314.
Venkatesan M, Amaratunga C, Campino S, Auburn S, Koch O, Lim P, et al. Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples. Malar J. 2012;11:41.
Snounou G, Pinheiro L, Gonçalves A, Fonseca L, Dias F, Brown KN, et al. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau. Trans R Soc Trop Med Hyg. 1993;87:649–53.
Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–8.
Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12: e1001788.
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2023.
OMS. Concentrations en hémoglobine permettant de diagnostiquer l’anémie et d’en évaluer la sévérité. Genève: Organisation Mondiale de la Santé; 2011.
Kulldorff M. A spatial scan statistic. Commun Stat Theory Methods. 1997;26:1481–96.
Ahmad A, Prom A, Bradley J, Ndiath M, Etoketim B, Bah M, et al. Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children. Malar J. 2021;20:169.
WHO. World malaria report 2017. Geneva: World Health Organization; 2017.
Filipe JAN, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC. Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol. 2007;3: e255.
Korenromp EL, Armstrong-Schellenberg JRM, Williams BG, Nahlen BL, Snow RW. Impact of malaria control on childhood anaemia in Africa—a quantitative review. Trop Med Int Health. 2004;9:1050–65.
White NJ. Anaemia and malaria. Malar J. 2018;17:371.
Tangena J-AA, Adiamoh M, D’Alessandro U, Jarju L, Jawara M, Jeffries D, et al. Alternative treatments for indoor residual spraying for malaria control in a village with pyrethroid- and ddt-resistant vectors in The Gambia. PLoS ONE. 2013;8: e74351.
Wilson AL, Pinder M, Bradley J, Donnelly MJ, Hamid-Adiamoh M, Jarju LBS, et al. Emergence of knock-down resistance in the Anopheles gambiae complex in the Upper River Region, The Gambia, and its relationship with malaria infection in children. Malar J. 2018;17:205.
Stresman GH, Mwesigwa J, Achan J, Giorgi E, Worwui A, Jawara M, et al. Do hotspots fuel malaria transmission: a village-scale spatio-temporal analysis of a 2-year cohort study in The Gambia. BMC Med. 2018;16:160.
Stadler E, Cromer D, Ogunlade S, Ongoiba A, Doumbo S, Kayentao K, et al. Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data. Malar J. 2023;22:42.
Färnert A, Williams TN, Mwangi TW, Ehlin A, Fegan G, Macharia A, et al. Transmission-dependent tolerance to multiclonal Plasmodium falciparum infection. J Infect Dis. 2009;200:1166–75.
Adu B, Issahaque Q, Sarkodie-Addo T, Kumordjie S, Kyei-Baafour E, Sinclear CK, et al. Microscopic and submicroscopic asymptomatic Plasmodium falciparum infections in Ghanaian children and protection against febrile malaria. Infect Immun. 2020;88:e00125-20.
Ademolue TW, Awandare GA. Evaluating antidisease immunity to malaria and implications for vaccine design. Immunology. 2018;153:423–34.
Kimenyi KM, Wamae K, Ochola-Oyier LI. Understanding P. falciparum asymptomatic infections: a proposition for a transcriptomic approach. Front Immunol. 2019;10:2398.
Add Comment